» Articles » PMID: 33521908

The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa

Overview
Journal AIDS Behav
Date 2021 Feb 1
PMID 33521908
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Despite high risk for HIV, South African adolescent girls and young women (AGYW) experience numerous challenges with adherence to PrEP. To better understand AGYW's motivations for PrEP and factors that impact PrEP adherence, we conducted serial in-depth interviews with 22 South African AGYW during a 12 month prospective study. Interviews explored motivations and initial experiences of PrEP use, patterns of adherence, social support, and reasons for stopping or persisting with PrEP. We also assessed drug levels as a biomarker of adherence; dried blood spots were collected at months 1, 2, 3, 6, and 12 to assess intracellular tenofovir diphosphate levels. An end-user journey analytical approach revealed themes related to behavioral and emotional aspects of use, including multilevel factors leading to divergent PrEP adherence trajectories. Our findings highlight how internal versus external motivations drive PrEP use, as well as how positive identity formation and challenges are handled, which are essential to understand AGYW in their PrEP journeys.

Citing Articles

Pre‑exposure Prophylaxis Awareness and Endorsement among Adolescents and Young Adults in Tanzania: Insights from the 2022 Demographic and Health Survey.

Kapola A, Musoke R, Manayon G, Fussi H, Bakari H, Ally H Ann Glob Health. 2025; 91(1):4.

PMID: 39896105 PMC: 11784521. DOI: 10.5334/aogh.4589.


Experiences with Oral Pre-Exposure Prophylaxis (PrEP) Service Delivery and Use Among Adolescent Girls and Young Women (AGYW) in Routine Primary Care Settings, South Africa.

Martin C, Muhwava L, Dada S, Scorgie F, Mullick S AIDS Behav. 2025; .

PMID: 39779628 DOI: 10.1007/s10461-024-04596-5.


Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review.

Admassu M, Nostlinger C, Hensen B BMC Womens Health. 2024; 24(1):665.

PMID: 39725977 PMC: 11670510. DOI: 10.1186/s12905-024-03516-y.


Applying CFIR to assess multi-level barriers to PrEP delivery in rural South Africa: Processes, gaps and opportunities for service delivery of current and future PrEP modalities.

Baron D, Leslie H, Mabetha D, Becker N, Kahn K, Lippman S Soc Sci Med. 2024; 361:117370.

PMID: 39366151 PMC: 11554290. DOI: 10.1016/j.socscimed.2024.117370.


Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A Longitudinal Qualitative Study from a Crossover Trial in South Africa, Uganda, and Zimbabwe.

Shapley-Quinn M, Tenza S, Jensen D, Tauya T, Mampuru L, Etima J AIDS Behav. 2024; 28(12):4209-4223.

PMID: 39343865 PMC: 11586305. DOI: 10.1007/s10461-024-04503-y.


References
1.
Celum C, Delany-Moretlwe S, Baeten J, van der Straten A, Hosek S, Bukusi E . HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019; 22 Suppl 4:e25298. PMC: 6643076. DOI: 10.1002/jia2.25298. View

2.
van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery E . Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014; 17(3 Suppl 2):19146. PMC: 4163995. DOI: 10.7448/IAS.17.3.19146. View